Looking at APA subgroups, our study found that 25% of the hospitalized COVID-19 patients had positive aCL IgM, 10.71% had positive aCL IgG, 7.14 % had positive aβ2GPI IgM and 50% of the tested patients had positive LA. The gene discussed is CD40LG; the disease is COVID-19.